scholarly journals Psychotic Disorders

Psychology ◽  
2014 ◽  
Author(s):  
Deborah J. Walder ◽  
Marta Statucka ◽  
Maureen Daly ◽  
Beril Yaffe

The term “psychotic disorders” refers to a broad conceptualization of conditions including primary psychoses, such as schizophrenia and psychotic mood disorders, other disorders that are sometimes marked by psychotic features (e.g., borderline personality disorder, body dysmorphic disorder), and secondary psychotic disorders due to medical conditions or substances (e.g., alcohol withdrawal delirium). As addressed in Ketter, et al. 2004 (“Psychotic Bipolar Disorders: Dimensionally Similar to or Categorically Different from Schizophrenia?,” cited in the Debate of Dimensional versus Categorical), controversy regarding relationships among mood disorders (particularly bipolar and depressive disorders with psychotic features) and schizophrenia is ongoing. The authors argue that while the respective dimensional (e.g., psychotic bipolar disorder as intermediate between non-psychotic bipolar and schizophrenia spectrum disorders) versus categorical debate persists, a mixed dimensional/categorical approach may best help elucidate pathophysiology and treatment options. Schizophrenia, specifically, is a severe and persistent form of mental illness often marked by positive symptoms (such as excesses and distortions in thoughts and sensory/perceptual experiences such as hallucinations and delusions), negative symptoms (behavioral deficits such as avolition, asociality, anhedonia, blunted affect, and alogia), disorganized symptoms (such as disorganized speech and behavior), movement symptoms (or grossly abnormal psychomotor behavior such as catatonia), and impairments in cognition (such as memory and frontal/executive functions that include, for example, planning ability and initiation). Kring, et al. 2014 (Abnormal Psychology, cited under the Schizophrenia Spectrum) provides an excellent introductory-level overview of schizophrenia and other psychotic disorders. The etiological (or causal) basis of schizophrenia and related psychotic disorders remains not wholly determined. Prevailing theories, however, ascribe to a diathesis-stress model, whereby biological factors (e.g., predispositions such as genetic liability) are believed to interact with adverse environmental factors (e.g., obstetric complications; adverse, stressful life events) over the course of development toward the manifestation of illness. This article offers a historical perspective of psychotic disorders, a review of etiological/theoretical models, a description of illness epidemiology and issues pertaining to sex differences and comorbidity, an outline of diagnostic considerations, a description of the schizophrenia spectrum, an examination of available assessment tools, the role of cognition/social cognition, a review of current evidence of neurobiological disruptions in psychosis (e.g., genetics, structural and functional neuroimaging, hormones, neurotransmitters, other aspects of maldevelopment in the central nervous system), other laboratory markers (e.g., perceptual and attentional abnormalities, smooth-pursuit eye movement dysfunction), environmental factors (such as stress, toxins, and familial-expressed emotion), the importance of gene-environment interactions in psychotic disorders, and, finally, current directions pertaining to prevention and treatment (pharmacological and psychosocial). While various psychotic-related disorders are addressed, this article focuses on the schizophrenia spectrum.

2018 ◽  
Vol 2018 ◽  
pp. 1-8 ◽  
Author(s):  
Soo Liang Ooi ◽  
Ruth Green ◽  
Sok Cheon Pak

N-acetylcysteine, a sulphur-containing amino acid for the treatment of paracetamol overdose and chronic obstructive pulmonary disease, is a widely available off-the-shelf oral antioxidant supplement in many countries. With the potential to modulate several neurological pathways, including glutamate dysregulation, oxidative stress, and inflammation that can be beneficial to the brain functions, N-acetylcysteine is being explored as an adjunctive therapy for many psychiatric conditions. This narrative review synthesises and presents the current evidence from systematic reviews, meta-analyses, and latest clinical trials on N-acetylcysteine for addiction and substance abuse, schizophrenia, obsessive-compulsive and related disorders, and mood disorders. Good evidence exists to support the use of N-acetylcysteine as an adjunct treatment to reduce the total and negative symptoms of schizophrenia. N-acetylcysteine also appears to be effective in reducing craving in substance use disorders, especially for the treatment of cocaine and cannabis use among young people, in addition to preventing relapse in already abstinent individuals. Effects of N-acetylcysteine on obsessive-compulsive and related disorders, as well as on mood disorders, remain unclear with mixed reviews, even though promising evidence does exist. Larger and better-designed studies are required to further investigate the clinical effectiveness of N-acetylcysteine in these areas. Oral N-acetylcysteine is safe and well tolerated without any considerable adverse effects. Current evidence supports its use as an adjunctive therapy clinically for psychiatric conditions, administered concomitantly with existing medications, with a recommended dosage between 2000 and 2400 mg/day.


2020 ◽  
pp. 103985622095371
Author(s):  
Louise Brightman ◽  
Alexandra Dunne ◽  
Hsin-Chia Carol Huang

Objective: Obesity is associated with co-morbid mental illness. The Canberra Obesity Management Service (OMS) supports adults with severe obesity who have the psychosocial capacity to engage. This study will determine whether mental illness is a predictor of OMS attendance and anthropometric changes. Method: A retrospective audit was performed from July 2016 to June 2017. Baseline characteristics, attendance and anthropometrics were stratified according to the presence of mental illness. Outcomes included weight stabilisation and clinically significant weight loss. Descriptive analyses were performed. Results: Mental illness was present in 60/162 patients (37%). Attendance was similar for those with and without mental illness. Patients with mental illness had twice as many co-morbidities ( p = .001). Depressive disorders were most common ( n = 28, 47%). Anxiety, schizophrenia spectrum and other psychotic disorders, and trauma- and stressor-related disorders also featured. Weight stabilisation was achieved by 25 patients (66%) with mental illness and 25 (35%) without. Clinically significant weight loss was observed in 10 patients (26%) with and 26 (40%) without mental illness. Conclusion: The presence of mental illness did not impact OMS attendance or weight stabilisation. The higher rate of co-morbidities in those with mental illness highlights the challenges faced by this vulnerable population.


Author(s):  
Daniel R. Strunk ◽  
Katherine Sasso

In this chapter, we provide an overview of the phenomenology of the mood disorders, including attention to both symptoms and functional impairment. Our overview emphasizes the heterogeneity among those with these disorders, as well as the most influential approaches to describing this variability across and within bipolar and depressive disorders. We discuss the degree of overlap between bipolar and depressive disorders, paying special attention to the clinical significance of low levels of manic symptoms. We also review several influential symptom-based specifiers, including those that refer to melancholic, atypical, anxious, and psychotic features. Having considered variability in the symptoms of these disorders, we then consider the course of these disorders. We survey the remarkable variability in course as well as current approaches to characterizing these differences. We conclude with a discussion of future directions.


Author(s):  
Martin Strassnig ◽  
Philip D. Harvey

Cognitive impairments are present in patients with severe mental illness (SMI) at the time of the first psychotic episode. People with schizophrenia are more impaired across the lifespan compared to bipolar patients or patients with major depression. Although schizophrenia patients appear to generally function on a lower level than bipolar patients, the functional correlates of cognitive impairment are similar. There is much less research on cognition and its functional impact in depression, with the depression literature largely focusing on the impact of symptoms and only some recent studies examining cognition and functional capacity. Complicating both bipolar and major depressive disorders is the influence of mood states on cognition. Moreover, patients with SMI are often medically compromised, with higher rates of obesity and related comorbidities as well as poor lifestyles, which add further cognitive and functional implications. Cognitive impairments are known determinants of disability in SMI and a rate-limiting step in recovering from mental illness. Treatment options are reviewed in this chapter, and potential ways forward are discussed.


BJPsych Open ◽  
2019 ◽  
Vol 5 (4) ◽  
Author(s):  
Alyson Zwicker ◽  
Lynn E. MacKenzie ◽  
Vladislav Drobinin ◽  
Emily Howes Vallis ◽  
Victoria C. Patterson ◽  
...  

Background Basic symptoms, defined as subjectively perceived disturbances in thought, perception and other essential mental processes, have been established as a predictor of psychotic disorders. However, the relationship between basic symptoms and family history of a transdiagnostic range of severe mental illness, including major depressive disorder, bipolar disorder and schizophrenia, has not been examined. Aims We sought to test whether non-severe mood disorders and severe mood and psychotic disorders in parents is associated with increased basic symptoms in their biological offspring. Method We measured basic symptoms using the Schizophrenia Proneness Instrument – Child and Youth Version in 332 youth aged 8–26 years, including 93 offspring of control parents, 92 offspring of a parent with non-severe mood disorders, and 147 offspring of a parent with severe mood and psychotic disorders. We tested the relationships between parent mental illness and offspring basic symptoms in mixed-effects linear regression models. Results Offspring of a parent with severe mood and psychotic disorders (B = 0.69, 95% CI 0.22–1.16, P = 0.004) or illness with psychotic features (B = 0.68, 95% CI 0.09–1.27, P = 0.023) had significantly higher basic symptom scores than control offspring. Offspring of a parent with non-severe mood disorders reported intermediate levels of basic symptoms, that did not significantly differ from control offspring. Conclusions Basic symptoms during childhood are a marker of familial risk of psychopathology that is related to severity and is not specific to psychotic illness. Declaration of interest None.


2011 ◽  
Vol 26 ◽  
pp. e153-e154 ◽  
Author(s):  
Islam Lucrezia ◽  
Demartini Benedetta ◽  
Selle Valerio ◽  
Gambini Orsola ◽  
Scarone Silvio

2005 ◽  
Vol 39 (1-2) ◽  
pp. 36-43 ◽  
Author(s):  
Anthony Harris ◽  
John Brennan ◽  
Josephine Anderson ◽  
Anne Taylor ◽  
Mark Sanbrook ◽  
...  

Objective: To examine the clinical profile, treatment and social functioning of a communitybased sample of young people presenting with their first episode of psychosis. Methods: Over a 2-year period, young people with their first episode of psychosis referred to early intervention services in two area mental health services in western Sydney were assessed with a battery of clinical, neuropsychological, psychophysiological and neuroanatomical measures. This paper reports the clinical results of the baseline section of the study. Results: Of the 224 referrals to the project, 94 subjects meet inclusion criteria and agreed to take part. Subjects were divided into three diagnostic groups – ‘Schizophrenia’, ‘Mood Disorders’ and ‘Mixed Psychosis’, the latter principally comprised of substance induced psychotic disorders. Subjects from the ‘Schizophrenia’ group differed significantly from the other two groups in that they had higher levels of negative symptoms and general psychopathology, and were less likely to be employed or engaged in study. They had poorer overall social functioning. Subjects with ‘Mixed Psychosis’ were similar to those from the ‘Schizophrenia’ group in that they were older and male, but they did not have the same burden of negative symptoms as the ‘Schizophrenia’ group. The ‘Mood Disorders’ group was younger, female and had overall a higher level of psychosocial functioning than the other two groups. Subjects from the ‘Mood Disorders’ group were more likely to be managed with mood stabilisers and multiple drug therapies. The use of atypical antipsychotic medication was almost universal. Conclusions: Even shortly after the time of presentation to mental health services young people with a schizophrenia spectrum diagnosis have a heavier burden of symptoms and are significantly more impaired by them than young people with other psychotic illnesses. This and their symptom profile differentiated them from young people with other psychotic disorders.


2010 ◽  
Vol 25 ◽  
pp. 1189
Author(s):  
L. Islam ◽  
B. Demartini ◽  
O. Gambini ◽  
S. Scarone

2020 ◽  
Author(s):  
Md Mahbub Hossain ◽  
Abida Sultana ◽  
Samia Tasnim ◽  
Qiping Fan ◽  
Ping Ma ◽  
...  

Introduction: Homelessness is a major problem that critically impacts the mental health and wellbeing of the affected individuals. This umbrella review aimed to evaluate the current evidence on the prevalence of mental disorders among homeless people from evidence-based systematic reviews and meta-analyses.Methods: We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and Joanna Briggs Institute (JBI) methodology for umbrella reviews. We searched 12 major databases and additional sources to identify systematically conducted reviews and meta-analyses reporting the prevalence of mental disorders among homeless populations.Results: We evaluated 1,277 citations and found 15 reviews meeting our criteria. Most studies were conducted among high-income countries with samples from different age groups. Studies reported high prevalence rates of depressive and anxiety disorders, schizophrenia spectrum and psychotic disorders, substance use disorders, suicidal behavior, bipolar and mood disorders, neurocognitive disorders, and other mental disorders among homeless people. Moreover, studies also reported a high burden of co-occurring mental and physical health problems among the homeless experiencing mental disorders.Conclusions: This umbrella review synthesized the current evidence on the epidemiological burden of mental disorders in homelessness. This evidence necessitates advanced research to explore psychosocial and epidemiological correlates and adopt multipronged interventions to prevent, identify, and treat mental disorders among homeless populations.


Sign in / Sign up

Export Citation Format

Share Document